Skip to main content

ADVERTISEMENT

Matthew J. Budoff, MD

Commentary
05/06/2010
Drug-eluting stents (DES) are currently implanted in > 3 million patients worldwide undergoing percutaneous coronary intervention (PCI) each year. With better equipment and understanding of the needs of prolonged dual-antiplatelet therapy...
Drug-eluting stents (DES) are currently implanted in > 3 million patients worldwide undergoing percutaneous coronary intervention (PCI) each year. With better equipment and understanding of the needs of prolonged dual-antiplatelet therapy...
Drug-eluting stents (DES) are...
05/06/2010
Journal of Invasive Cardiology
Commentary
07/06/2010
   The importance of atherosclerotic lesion characteristics in determining long-term vessel patency and rate of complications after a percutaneous coronary intervention (PCI) has been recognized virtually since the inception of coronary...
   The importance of atherosclerotic lesion characteristics in determining long-term vessel patency and rate of complications after a percutaneous coronary intervention (PCI) has been recognized virtually since the inception of coronary...
   The importance of...
07/06/2010
Journal of Invasive Cardiology
Commentary
03/04/2010
Cath Lab Digest